Home Search
silo - search results
If you're not happy with the results, please do another search
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).
Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!
Advances in Psychedelics can Change Investors’ Minds
Original article(s) on EXBulletin and Financial Times
The science behind this subject has become mainstream in recent years. Excellent...
That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...
Redefining how the world approaches, prevents, and heals mental health disorders.
LIVE QUOTE
CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).
Therapy Treatment Performed by Ehave's (EHVVF) Chief Medical Office Receive Rave Reviews and Offers Potential to Save Lives,
Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).
Originally in PsyTech Jan 28, 2021.
By Tessa Eskin
Big Pharma is at a crossroads....
Citius (CTXR) Announces Results of Mino-Lok Study.
"Mino-Lok has the potential to change the standard of care, which currently calls for a procedure to remove and replace the infected...
Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion.
Shares jumped 71% to $29 in New York after an initial public offering of 7.5 million shares priced at $17 each...
Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
TORONTO, April...
Latest article
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such...
